Stock Market Insights: Top Picks for Next Week
As the stock market navigates a turbulent landscape, Bajaj Broking Research has identified Piramal Pharma and PTC India as the leading stock recommendations for the week starting March 17, 2025. With ongoing volatility in the Nifty and Bank Nifty indices, investors are urged to consider these stocks amid fluctuating global cues and economic indicators.
Nifty Index: Navigating Volatility
The Nifty index continues to face significant volatility, influenced by shifting global market conditions. Recent trade tensions and varying U.S. policies have created a challenging environment for traders. Over the past several sessions, the Nifty has consolidated after a notable increase of 700 points. Currently, immediate support is observed between 22,200 and 22,300, which is crucial for maintaining upward momentum towards the 22,700 and 23,000 levels in the upcoming week. Key support levels for the Nifty are identified at 22,000 to 21,700. This range includes the long-term 100-week exponential moving average (EMA), which has historically provided support during major corrections. Additionally, a rising demand line support, connecting lows from June 2022 and March 2023, is positioned around 21,900. The confluence of previous major lows and key retracement levels further strengthens this support zone. Several factors are currently bolstering the market. The U.S. Dollar Index has dipped below the 105-106 range, creating a favorable environment for emerging markets. Furthermore, Brent Crude prices remain below the $72-75 mark, positively impacting India’s economic outlook. The U.S. 10-year Treasury yield has also decreased to 4.25%, which is expected to benefit emerging markets like India.
Bank Nifty: A Cautious Outlook
The Bank Nifty index has formed a high wave candle, indicating a pattern of lower highs and lower lows for five consecutive weeks. Over the past nine weeks, the index has been consolidating within a broad range of 47,800 to 50,500. A close below this lower boundary could accelerate declines towards the 47,000 level in the coming weeks. Conversely, maintaining levels above this range could lead to a potential pullback towards 49,000. Investors should remain vigilant as the Bank Nifty navigates this consolidation phase. The index’s performance will be closely monitored, as any significant movements could signal broader market trends.
Stock Recommendations: Piramal Pharma and PTC India
Piramal Pharma
Bajaj Broking recommends buying Piramal Pharma within the price range of Rs 193-203. The stock has recently formed a base around the long-term 52-week EMA, presenting a favorable risk-reward setup for investors. The target price for Piramal Pharma is set at Rs 229, indicating a potential return of 16% over the next 12 months. The stock’s recent correction has created an entry opportunity, and technical indicators suggest a positive bias.
PTC India
PTC India is also highlighted as a strong buy, with a recommended entry range of Rs 150-157. The stock has recently broken out of a three-month trading range, signaling a resumption of upward momentum. The target price for PTC India is Rs 178, which represents a 16% potential return over the next year. The stock’s breakout and positive technical signals validate the bullish outlook.
Observer Voice is the one stop site for National, International news, Sports, Editor’s Choice, Art/culture contents, Quotes and much more. We also cover historical contents. Historical contents includes World History, Indian History, and what happened today. The website also covers Entertainment across the India and World.
